Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.
about
Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalGenetic alterations in hepatocellular carcinoma: An updateIdentification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivoAn integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma.Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo.The p53R172H mutant does not enhance hepatocellular carcinoma development and progression.Prognostic significance of p53 expression in patients with esophageal cancer: a meta-analysis.Immunohistochemical Determination of p53 Protein Overexpression for Predicting p53 Gene Mutations in Hepatocellular Carcinoma: A Meta-Analysis.Prognostic value of DNA repair based stratification of hepatocellular carcinomaIncreased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways.Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.Preoperative γ-glutamyl transpeptidase to platelet ratio (GPR) is an independent prognostic factor for HBV-related hepatocellular carcinoma after curative hepatic resection.Prognostic value of p53 mutation for poor outcome of Asian primary liver cancer patients: evidence from a cohort study and meta-analysis of 988 patientsPrognostic role of pre-treatment serum AFP-L3% in hepatocellular carcinoma: systematic review and meta-analysis.TP53 mutation is associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a meta-analysis.Cellular and molecular mechanisms of hepatocellular carcinoma: an update.Autoantibodies to tumor-associated antigens as biomarkers in human hepatocellular carcinoma (HCC).A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.p53 in liver pathologies-taking the good with the bad.Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis.Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line.CP-31398 inhibits the growth of p53-mutated liver cancer cells in vitro and in vivo.ALDH1L1 variant rs2276724 and mRNA expression predict post-operative clinical outcomes and are associated with TP53 expression in HBV-related hepatocellular carcinoma.NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity.Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition.Clinical significance of PICT1 in patients of hepatocellular carcinoma with wild-type TP53.TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis.Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma.A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer.Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck.p53-Mediated Molecular Control of Autophagy in Tumor Cells.Roles of p53 in extrinsic factor-induced liver carcinogenesis
P2860
Q26853543-C630237C-1660-41E7-BD66-57FACBB65FFCQ28073241-A7E761B7-A895-40EC-8DBF-37E98CD2F894Q33917547-3932BC84-C6C4-41C4-879F-269CD095B0AEQ34402163-07F4EB4D-0AFA-405E-85DD-E373C01D28B8Q34497012-8D9F8220-1B8B-4945-9892-C252D575B3E9Q34973753-B7DF55C0-D832-4FCE-919D-356334E33FCCQ35138721-38020B67-50E6-49AB-A42E-BE0A785ADB85Q35605993-2D7E9353-7F2C-4BEE-8B68-64D491080BEAQ36066420-8AE6C13C-A8A8-4022-BC92-2510B819B99FQ36079974-00874748-87CC-446A-B85E-2C88C93C3F01Q36903275-1BE98886-BA1F-4F8D-BB9F-56487F3617DCQ37041562-E0256705-7EE9-438F-8E9D-77681FF2364EQ37295260-E5FE1F25-9AF5-441B-8F6B-C8F388075A4EQ37328031-DACC7F76-74BF-4AA8-BA36-7AB5685C20FCQ37496567-FB823E6B-1B19-4A4F-9F03-2D51E54A89C4Q37534070-973D6466-2DAF-47BE-AE7B-D4E8C07AB873Q37584718-3F624051-C6D9-4613-9749-17C6505B12C5Q38046107-CF73A338-97B0-4236-911F-6B9C09665BCEQ38107971-02C3EDB5-8805-408A-ABFA-2D89F8350B40Q38135317-6DA22BB4-2367-427A-929B-F1CD1F8ED858Q38268953-05D6C55B-2CA0-4580-9AD4-34B8970594A9Q38280688-2A80BFAA-31B9-4C1B-B0F4-34F864B61C12Q38765553-61E7B439-ADB3-4994-B35B-A3727AC9883FQ38845711-EAC76330-EC75-4A91-A360-39A5DF67EA08Q40120564-1DBDB666-E83A-4882-BB6D-A2589D8E25A8Q41585790-8C9B90C8-C3E0-455E-9962-03A9453C1412Q42282841-3D554247-A6D2-4C5B-B00B-356D3A9EBF0EQ45910989-93BBA67E-97C3-4F54-8C6E-14784E945920Q46151710-4D0B4707-6D69-465D-8985-B29C5550401BQ47135856-D0EDBAC8-330D-49B7-9534-48DADC263A72Q48225584-9B152D0E-03EA-4F8B-8809-C795D1840FA0Q50197086-7862A267-B6E1-42FB-B757-0F0F1C9FC9DCQ52645040-0F25D8AF-EAAA-474C-A0B4-31D88B560FDAQ56972496-B88576B6-4C65-4310-AE51-0C5440D8C8E3
P2860
Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Alterations of TP53 are associ ...... atic review and meta-analysis.
@ast
Alterations of TP53 are associ ...... atic review and meta-analysis.
@en
type
label
Alterations of TP53 are associ ...... atic review and meta-analysis.
@ast
Alterations of TP53 are associ ...... atic review and meta-analysis.
@en
prefLabel
Alterations of TP53 are associ ...... atic review and meta-analysis.
@ast
Alterations of TP53 are associ ...... atic review and meta-analysis.
@en
P2093
P2860
P1476
Alterations of TP53 are associ ...... atic review and meta-analysis.
@en
P2093
Dong Zhang
Fengfei Wang
Jiangbo Liu
Qingyong Ma
Xinshuai Wang
P2860
P304
P356
10.1016/J.EJCA.2012.03.001
P577
2012-03-27T00:00:00Z